Rheumatic Disorders

Daniel Solomon, MD, MPH, on Interleukin-1 Blockade to Prevent Gout Attacks

08/05/2019

 

 

Daniel Solomon, MD, MPH, from Brigham and Women's Hospital, discusses what rheumatologists should know about interleukin-1β inhibitors, findings from his study of canakinumab for the prevention of gout, and more.   

Daniel Solomon, MD, MPH, is a professor of medicine at Harvard Medical School and chief of clinical science in the Division of Rheumatology at Brigham and Women’s Hospital in Massachusetts. 

Read more about Dr Solomon’s study here.

Related Content

Cardiometabolic Risk
Cardiometabolic Risk
Daniel Einhorn, MD, on Treating CVD in Diabetes
02/06/2019
Dr Daniel Einhorn from the Scripps Whittier Diabetes Institute talks about how the latest diabetes guidelines impacts treatment for patients with comorbid cardiovascular disease.
02/06/2019
Primary Care
Primary Care
Expert Conversations: PCMH for the Practicing Physician
05/29/2018
Michael S. Barr, MD, and Patricia Barrett from the National Committee for Quality Assurance discuss Patient-Centered Home Care for the primary care provider.
05/29/2018
Multiple Sclerosis
Multiple Sclerosis
Abbey Hughes, MD, on Using the GAD-2 for Screening Anxiety in Patients With MS
11/06/2018
Dr Abbey Hughes from Johns Hopkins University School of Medicine talks about her research on anxiety screening in patients with multiple sclerosis.
11/06/2018
Asthma
Asthma
ATS President Marc Moss, MD, on Improving Patient Care
08/17/2017
<p>Dr Marc Moss, from the University of Colorado, has recently been appointed President of the American Thoracic Society. Hear about his plans for the future in this short...
08/17/2017
Podcast
Podcast
Repository Corticotropin Injection as Therapy for Rheumatoid Arthritis
01/19/2023
Dr Basu discusses current treatment options for patients with rheumatoid arthritis (RA) and repository corticotropin injection as a therapeutic option for patients with refractory disease.
01/19/2023